JMP Clinical software from SAS simplifies data discovery, analysis and reporting in clinical trials, bringing greater efficiency and accuracy to studies of safety and efficacy data at every phase of the drug development process: pre-clinical, clinical and post-market. New risk-based monitoring tools in JMP Clinical 5 limit costly on-site reviews while maintaining the well-being of study participants. These features tie in seamlessly with fraud detection, data monitoring and statistical analysis capabilities to reduce trial failure. JMP Clinical combines the industry-leading power of SAS® Analytics with the graphical flexibility of JMP, the longstanding tool of choice of medical reviewers at the US Food and Drug Administration.Workflows, templates and reporting tools customized according to user role make it easy for data monitors, medical writers, biostatisticians and data managers to see and explore trends and outliers, and then communicate their discoveries.Clinicians without programming experience or statistical training can generate clinically relevant results. Advanced analysts enjoy effortless access to the statistical analysis options and code behind the graphics – a benefit not found in other software.
21 January 2017
20 December 2016